A full-thickness cartilage injury in the knee can be one of the most difficult diagnoses for an elite athlete. It can affect performance, limit training, and raise major questions about whether a return to competition is realistic. A 2025 study including Dr Jobe Shatrov looked at outcomes after microfracture in elite athletes and found that return-to-play rates were high, particularly in carefully selected cases.

This is encouraging research, but it also provides a more realistic picture of what happens over time.

Why cartilage injuries matter in sport

Articular cartilage helps the knee move smoothly and absorb load. When a full-thickness cartilage lesion develops, that surface is disrupted. For athletes, that can lead to:

• pain

• swelling

• reduced confidence in the joint

• difficulty training and competing

Microfracture is one treatment option designed to stimulate repair tissue. It has been used for many years, but its durability in high-level athletes has sometimes been questioned.

What the study set out to test

The researchers reviewed elite athletes who had undergone microfracture for full-thickness cartilage injuries of the knee. They wanted to know:

• how many athletes returned to elite sport

• how long it took

• which factors influenced both return and longer-term continued participation

Return-to-play was defined at a high competitive level, not simply returning to light recreational activity.

What the study found

The return-to-play rate was high, which is reassuring for athletes. Many athletes were able to get back to competition after microfracture.

However, the study also found that long-term continuation in elite sport was influenced by the pattern of the cartilage injury. Larger lesions and multiple lesions made longer-term continued participation less predictable.

That means the early return story can be positive, but the longer-term outlook still depends on the size and complexity of the injury.

What this means for athletes

This paper is useful because it gives both encouragement and realism. It shows that microfracture does not automatically mean the end of elite sport. But it also makes clear that “returning” and “staying at the same level long term” are not always the same thing.

For athletes, the discussion is not only about whether you will get back to sport, but also:

• how durable that return will be

• what demands your sport places on the knee

• how large or complex the lesion is

Why lesion size matters

One of the key messages is that smaller, isolated lesions appear more favourable. Larger lesions, or more than one lesion, reduce the likelihood of long-term continued elite participation.

This does not mean the surgery has failed in those patients. It means the biological challenge is greater, and the demands of elite sport may expose the limits of the repair tissue over time.

What this means in practice

For athletes and clinicians, the study supports a balanced treatment discussion:

• microfracture can still be a valuable treatment option

• early return to sport can be realistic

• long-term durability depends on the lesion and the demands of the athlete’s sport

It also reinforces the importance of a strong rehabilitation plan and realistic expectations.

Key takeaways

• Microfracture can support return to elite sport after full-thickness cartilage injury.

• Return-to-play rates were high in this group of elite athletes.

• Larger or multiple lesions reduce the likelihood of long-term continued elite participation.

• The study supports realistic conversations about both early return and long-term durability.

Read the full paper: https://esskajournals.onlinelibrary.wiley.com/doi/10.1002/ksa.12808